ClearOne cancels warrants, locks in CFO, and gets shareholder nod for merger share issuance

What happened

ClearOne, Inc. (NASDAQ: CLRO), a provider of audio and video communication solutions, disclosed three material events in an August 5, 2026 8-K filing. The events are all linked to ClearOne’s July 1, 2026 Agreement and Plan of Merger with CLRO Merger Sub, Inc., Cortigent, Inc. and Vivani Medical, Inc.

On August 4, 2026, ClearOne and its majority stockholder, First Finance Ltd., signed a Warrant Cancellation Agreement that extinguishes warrants to buy 437,500 shares of ClearOne common stock at $5.00 per share. Those warrants were originally issued with a two-year term. The cancellation is directly tied to the merger agreement.

Separately, on July 31, 2026, ClearOne entered into an employment agreement with Simon Brewer, who will serve as chief financial officer. The agreement takes effect upon completion of the Cortigent acquisition. Brewer receives a $300,000 annual base salary, eligibility for an annual discretionary bonus, and stock options to buy 200,000 shares at the price of the financing that will be completed in connection with the merger. The options vest 25% per year. The agreement includes severance and non-solicitation terms.

On August 3, 2026, First Finance Ltd., which held 1,641,162 shares (about 61.3% of voting power) as of July 31, 2026, passed resolutions by written consent to approve (i) the issuance of 12,500,000 shares of common stock in connection with the merger—an issuance that exceeds 20% of ClearOne’s outstanding stock and triggers a change of control under Nasdaq rules—and (ii) the adoption of ClearOne’s 2026 Omnibus Incentive Plan. ClearOne will file a Schedule 14C information statement with the SEC and mail it to stockholders; it plans to implement the stock issuance and plan adoption no earlier than 20 calendar days after that mailing begins.

ClearOne’s stock closed at $10.17 on August 5, up 3.78% from the prior close of $9.80.

The warrant cancellation

The Warrant Cancellation Agreement between ClearOne and First Finance Ltd. eliminates warrants to purchase 437,500 shares at $5.00 per share. Warrants are contracts that give the holder the right to buy stock at a fixed price for a set period. By cancelling them, ClearOne removes potential dilution from those warrants. The filing states the cancellation was made “in connection with” the Merger Agreement, though it does not explain the exact reason—for instance, whether it was a condition of the merger or a simplification of the capital structure before closing.

The CFO employment agreement

Simon Brewer, already serving as CFO, signed an employment agreement effective when the acquisition of Cortigent closes. The contract is for an indefinite term, with either party able to terminate on 30 days’ written notice. Key financial terms: a $300,000 base salary, a discretionary annual performance bonus, and stock options for 200,000 shares. The option exercise price will be the price of the financing done alongside the Cortigent acquisition—so the price is not yet fixed. Options vest at 25% per year. If ClearOne terminates Brewer without cause (or if he resigns for “good reason”), he gets six months’ salary severance and continued COBRA benefits for six months. He also agreed to a 12-month non-solicitation of employees and customers and a non-disparagement clause.

Shareholder vote by written consent

Instead of holding a meeting, ClearOne obtained stockholder approval through a written consent from the holder of a majority of voting power, First Finance Ltd. This is permitted under Nevada corporate law and Nasdaq rules when a single stockholder or group holds enough votes. The consent approved two items: (1) issuing 12,500,000 shares—more than 20% of the currently outstanding common stock—in connection with the merger, which under Nasdaq Listing Rules 5635(a) and (b) requires stockholder approval because it exceeds 20% and results in a change of control; and (2) adopting the 2026 Omnibus Incentive Plan, which will govern future equity awards.

Because this was a written consent rather than a meeting, ClearOne must distribute an information statement (Schedule 14C) to all stockholders at least 20 calendar days before implementing the approved items. The merger agreement and the incentive plan will be attached as appendices to that statement. The stock issuance and plan adoption cannot take effect until that 20-day period ends.

What this means

A Form 8-K is used to disclose material events that shareholders should know about between quarterly reports. Items 1.01, 5.02, and 5.07 each cover a specific type of event: a material agreement, a change in officers, and shareholder voting results, respectively.

The warrant cancellation removes a potential source of dilution at a $5.00 exercise price, which was well below the current market price of $10.17. Clearing those warrants simplifies the ownership structure ahead of the merger.

The employment agreement for Simon Brewer locks in the CFO on terms that are typical for a senior executive: salary, bonus eligibility, long-term equity incentives (the options), severance, and restrictive covenants. The fact that the options’ exercise price will be set at the merger financing price indicates that the option grant is tied to the new capital structure of the post-merger company.

The written consent from First Finance Ltd. effectively gives the merger and the share issuance the green light from ClearOne’s stockholders, since First Finance holds a majority. The 20-day waiting period before the stock issuance can happen is a standard SEC requirement for actions taken by written consent, giving other stockholders time to review the information statement.

Taken together, these filings show ClearOne moving forward with a merger that will involve a major stock issuance and a change of control. The next step is the mailing of the Schedule 14C, followed by the closing of the merger, which will trigger the CFO agreement and the issuance of shares.